Generalized
Convulsive
Non-convulsive
Focal
Convulsive (epilepsia partialis continua)
Non-convulsive
Non-epileptic (“Pseudo-SE”)
The task force on SE of the ILAE Commission on European Affairs has suggested a more exhaustive classification, as shown in Table 8.2 [2].
Classification of SE |
1. NCSE occurring in the neonatal and infantile epilepsy syndromes a. Ohtahara syndrome b. West syndrome c. Sever myoclonic encephalopathy of infancy (SMEI; Dravet syndrome) 2. NCSE occurring only in childhood a. NCSE is early-onset benign childhood occipital epilepsy (Panayiotopoulos syndrome) b. NCSE in other forms of childhood epileptic encephalopathies, syndromes, and etiologies (e.g., Ring chromosome 20, Angelman syndrome, Rett syndrome, myoclonic-astatic epilepsy, and other childhood myoclonic encephalopathies c. Electrical status epilepticus in slow wave sleep (ESES) d. Landau–Kleffner syndrome 3. Convulsive SE occurring only in childhood a. Febrille SE 4. NCSE occurring both in childhood and adult life with epileptic encephalopathy a. NCSE in the Lennox–Gastaut syndrome i. Atypical absence SE ii. Tonic SE b. Other forms of NCSE in patients with learning disability or disturbed decerebral development (cryptogenic or symptomatic) without epileptic encephalopathy c. Typical absence SE in idiopathic generalized epilepsy d. Complex partial SE: i. Limbic ii. Nonlimbic e. NCSE in the post-ictal phase of tonic–clonic seizures f. Subtle SE (myoclonic SE occurring in the late stage of convulsive SE) g. Aura continua [with (i) sensory, (ii) special sensory, (iii) autonomic, and (iv) cognitive symptoms] 5. Convulsive forms of SE occurring in childhood and adult life a. Tonic–clonic status epilepticus b. Epilepsia partialis continua 9 EPC; simple partial motor SE c. Myoclonic SE 6. NCSE occurring in late adult life a. De novo absence SE of late onset 7. Boundary syndromesa a. Some cases of epileptic encephalopathy b. Some cases of coma due to acute brain injury with epileptiform EEG changes c. Some cases of epileptic behavioral disturbances or psychosis d. Some cases of drug-induced or metabolic confusional state with epileptiform EEG changes |
Non–convulsive status epilepticus (NCSE) is common and continues to be underdiagnosed. Continuous video-EEG monitoring is essential for its diagnosis. NCSE may present with altered mental status or psychosis, as well as with focal non-convulsive neurological symptoms or deficits. Seizures may not be picked up on a routine EEG, and the diagnosis may be missed unless 24-h-continuous video-EEG (CEEG) monitoring is performed.
In a study of 570 adults with unexplained decrease in level of consciousness who underwent CEEG monitoring, seizures were detected in 19% of the patients. Seizures were exclusively non-convulsive in 92% of these patients. Coma, age <18 years, history of prior epilepsy and convulsive seizures prior to monitoring were the risk factors for electrographic seizures. Seizures were detected during the first 24 h of CEEG monitoring in 88% of patients, during day 2 of monitoring in another 5%, and after 48 h of monitoring in 7%. 20% of comatose patients required >24 h of monitoring to detect the first electrographic seizure versus 5% of non-comatose patients. Prevalence of NCSE by diagnosis is shown in Table 8.3 [3].
% | |
---|---|
Overall | 18 |
Unexplained altered MS | 15 |
Epilepsy | 31 |
CNS infection | 26 |
Tumor | 23 |
Neurosurgery | 23 |
Traumatic brain injury | 22 |
Toxic-metabolic | 21 |
Stroke-SAH | 18 |
Stroke-hemorrhagic | 13 |
Stroke-ischemic | 13 |
Hypoxia | 10 |
The diagnosis of non-convulsive status epilepticus in patients with altered mental status and ambivalent EEG can be aided with intravenous benzodiazepine bolus injection, e.g., lorazepam 1 mg, which may abolish the epileptiform discharges, sometimes with associated paradoxical improvement of the patient’s level of consciousness.
Etiology of SE for adults and children is shown in Table 8.4 [4].
Adult | % | Pediatric | % |
---|---|---|---|
CVA | 25 | Fever/infection | 35 |
ASM change | 19 | ASM change | 20 |
EtOH/recr. drugs | 12 | Unknown | 9 |
Anoxia | 11 | Metabolic | 8 |
Metabolic | 9 | Congenital | 7 |
Unknown | 8 | Anoxia | 5 |
Fever/infection | 5 | CNS infection | 5 |
TBI | 5 | 4 | |
Tumor | 4 | CVA | 3 |
CNS infection | 2 | EtOH/recr. drugs | 2 |
Congenital | 1 | Tumor | 1 |
A variable proportion of patients with status have preceding the history of epilepsy, in some studies estimated up to approximately 45%. In approximately 50% of patients with preceding epilepsy, the epilepsy is acute symptomatic. It is remote symptomatic in 20% cases, idiopathic in 14%, and unclassified in 17%.
Etiology of epilepsia partialis continua is usually due to a fixed or progressive lesion involving the motor strip. These include tumors, vascular lesions (CVA, AVM), infection (abscess—especially TB, encephalitis, HIV, and subacute measles encephalopathy), autoimmune (Rasmussen), systemic lupus erythematosus (SLE), paraneoplastic, cortical dysplasia, Sturge–Weber syndrome, traumatic brain injury (TBI), multiple sclerosis, gliomatosis cerebri, or progressive multifocal leucoencephalopathy.
Medications that may cause SE include theophylline, lithium, isoniazid, cyclosporine, tacrolimus, ifosfamide, amoxapine, flumazenil, and among antiseizure medications (ASMs) tiagabine, vigabatrin and valproate.
Uncommon causes of SE include the following:
Paraneoplastic etiology, with associated autoantibodies (i) Hu, (ii) Ma2, and (iii) CRMP-5—all of them target intracellular antigens. Most common associated neoplasms are small cell lung carcinoma (associated with all of the above antibodies), testicular germ call carcinoma (Ma2), and thymoma (CRMP5). In these conditions, SE may be refractory and respond to tumor removal.
Autoimmune diseases including Hashimoto’s thyroiditis, SLE, Rasmussen’s encephalitis syndrome, with associated thyroid microsomal antibodies, voltage-gated K channels antibodies, NMDA-receptor antibodies, all of which are extracellular antigens. Rasmussen’s encephalitis syndrome is associated with anti-NR2A antibody (NMDA-receptor subunit GluRepsilon2).
Infectious, ill–defined include the recently described new-onset refractory SE (NORSE) in adults and febrile infection-related epilepsy syndrome (FIRES) in previously normal children.
Chromosomal, genetic, or congenital dysplastic and inborn errors of metabolism, all covered elsewhere in this book.
SE Clinical Stages
SE is divided into 4 phases (Table 8.5). Prodromal phase may include confusion, myoclonus, and increasing seizure frequency without intervening loss of consciousness. Stage 1 is divided into incipient (continued seizure of >5 min duration) and early (5–30 min duration).
Table 8.5
Clinical stages of status epilepticus
Prodromal | ||
---|---|---|
Stage 1 (early) | Incipient | 5 min |
Early | 5–30 min | |
Stage 2 (established) | 30–60 min | |
Stage 3 (refractory) | >60 min | |
Post-ictal |
EEG staging includes (i) discrete seizures with interictal slowing; (ii) waxing/waning of ictal discharges; (iii) continuous ictal discharge evolving into continuous ictal discharges interspersed by flat EEG; and (iv) Post-ictal: PLEDs/PEDs with flat background [5].
Pathophysiology of SE
SE evolves from an isolated seizure when there is a failure of seizure containment leading to the transformation of isolated seizure(s) to SE. Initially (ms/s), there is increased glutamate release and ion channel activation receptor phosphorylation and desensitization. After approximately 30–45 min, there is receptor trafficking with GABAA-R (β2-3, ɤ subunits) internalized from synapse to cytosol where they are endocytosed and destroyed, leading to reduced number of GABAA receptors at the synaptic membrane, with simultaneous recruitment from cytosol to the membrane of glutamatergic AMPA/NMDA receptors (NR1 subunits). As a result of this trafficking, the number of functional NMDA receptors per synapse increases while the number of functional GABAA receptors decreases [6]. This contributes to the resistance of prolonged SE to GABAergic medication such as benzodiazepines.
Pathophysiology of epilepsia partialis continua is poorly understood. It may involve cortical reflex myoclonus which originates from hypersynchronous discharges of neuronal aggregates in the cortex and may involve long-loop reflexes via the ventrolateral posterior nucleus of the thalamus to generate cortical myoclonus [7].
Metabolic Consequences of SE (Table 8.6)
During the initial acute stage of SE, there is an increase in blood pressure, increase in cerebral blood flow and oxygen utilization, increased serum lactate, and, initially, increased glucose levels. There may be associated respiratory and metabolic acidosis. Subsequently, blood pressure normalizes and may fall, respiration becomes depressed, with falling oxygen and rising CO2 levels, decrease in cerebral blood flow and brain oxygenation, and decrease in glucose level. There may be hyperthermia. These factors result in energy mismatch, with higher brain energy utilization than supply and exacerbation of neuronal injury. During later stages of both convulsive SE and in NCSE, there is an increase in serum levels of neuron-specific enolase, a marker of brain injury. Neuronal injury may occur even in the absence of metabolic derangement, and without hypoxemia, hypotension, hypoglycemia, and hyperthermia.
Cerebral | Hypoxic/metabolic damage |
Excitotoxic damage | |
Edema and ↑ ICP | |
Venous thrombosis, infarction, hemorrhage | |
Cardiac | Hypo/hypertension |
Cardiac failure/shock | |
Tachy-/brady-arrhythmia, arrest | |
Respiratory | Apnea, respiratory failure
![]() Stay updated, free articles. Join our Telegram channel![]() Full access? Get Clinical Tree![]() ![]() ![]() |